Director of Genetic Consultation and Counseling Services, Center for Applied Genetics and Genomic Medicine
Member, University of Arizona Cancer Center
Medical Education Director, Partnership for Native American Cancer Prevention
University of Arizona College of Medicine
Internal Contact Information
Dr. Laukaitis' professional goal is to understand the genetic and environmental risk factors that predispose individuals to cancer in order to treat neoplasia before cancer develops. Her training and board certification in Medical Genetics have provided her with expertise, and to experience caring for people at high-risk for breast and other cancers due to mutations in BRCA1, BRCA2, APC and mismatch repair genes. In Dr. Laukaitis' laboratory, they seek explanations for high-risk families without identified mutations.
Dr. Laukaitis has experience working with WBF and UDCA sample genotyping and experience interpreting genetic data that influences cancer risk.
My professional goal is to provide individual risk assessment and counseling to develop a plan for treating neoplasia before metastatic cancer develops in people at high-risk of cancer because of genetic factors. My training and board certification in Medical Genetics have provided me with expertise and experience caring for people at high-risk for breast cancer due to mutations in BRCA1, BRCA2, APC and mismatch repair genes genes. I will couple this with my laboratory background to translate advances understanding additional genes influencing cancer risk into new clinical tests for my patients. I will seek to apply these advances to all of my patients, regardless of racial, ethnic, or socio-economic background.
A second research direction addresses appropriate targeting of chemoprevention strategies. I am participating in a project to test the safety of using DFMO and sulindac as a chemopreventive strategy in children with FAP, which we hope to follow with a study of efficacy.
Visit the Laukaitis Laboratory site to learn more
Publications most relevent to current research
- Burton BK, et al. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. N Engl J Med. 2015 Sep 10;373(11):1010-20. doi: 10.1056/NEJMoa1501365. PubMed PMID: 26352813.
- Laukaitis, C.M. (2012) Genetics for the General Internist. American Journal of Medicine 125(1):7-13. PMID: 22079017.
- Laukaitis, C.M., Erdman, S.H. and Gerner, E.W. (2012) Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer 1(3):241-256.
- Laukaitis, C.M. and Gerner, E.W. (2011) DFMO: Targeted Risk Reduction Therapy. Best Practice and Research: Clinical Gastroenterology. 25(4-5):495-506. PMID: 22122766.
- Zhou, X., Wei, Y., Xie, F., Laukaitis, C.M., Karn, R.C., Kluetzman, K., Gu, J., Zhang, Q-Y., Roberts, D.W., and Ding, X. (2011) A Novel Defensive Mechanism against Acetaminophen Toxicity in the Mouse Lateral Nasal Gland: Role of CYP2A5-Mediated Regulation of Testosterone Homeostasis and Salivary Androgen-Binding Protein Expression. Molecular Toxicology. 79(4):710-23. PMID: 21252290
- Karn, R.C. and Laukaitis, C.M. (2011) Positive selection shaped the convergent evolution of independently expanded kallikrein subfamilies expressed in mouse and rat saliva proteomes. PLoS One. 6(6):e20979. PMID: 21695125
Additional recent publications of importance to the field
- Laukaitis, C. M., Critser, E. S. and Karn, R. C. (1997) Salivary androgen-binding protein (ABP) mediates sexual isolation in Mus Musculus. Evolution. 51(16): 2000-2005.
- Knight, B., Laukaitis, C. M., Akhtar, N., Hotchin, N. A., Edlund, M. and Horwitz, A. R. (2000) Visualizing cell migration in situ. Current Biology. 10: 576-585. PMID: 10837222
- Laukaitis, C. M., Donais, K., Webb, D. J., and Horwitz, A. F. (2001) Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. Journal of Cell Biology. 153(7):1427-1440. PMID: 11425873
- Laukaitis, C.M., Dlouhy, S.R., and Karn, R.C. (2003) The mouse salivary androgen-binding protein (ABP) gene cluster on chromosome 7: Characterization and evolutionary relationships. Mammalian Genome. 14:679-691. PMID: 14694904
- Laukaitis, C.M., Dlouhy, S.R., Emes, R.D., Ponting, C.P., and Karn, R.C. (2005) Diverse spatial, temporal, and sexual expression of recently duplicated androgen-binding protein genes in Mus musculus. BMC Evolutionary Biology. 5:40. PMID: 16018816
- Laukaitis, C.M., Heger, A., Blakley, T.D., Munclinger, P., Ponting, C.P., and Karn, R.C. (2008) Rapid bursts of Abp gene duplication occurred independently in diverse mammals. BMC Evolutionary Biology. 8:46. PMID: 18269759
- Karn, R.C. and Laukaitis, C.M. (2009) The mechanism of expansion and the volatility it created in three pheromone gene clusters in the mouse (Mus musculus) genome. Genome Biology and Evolution. 2009:494-503. PMID: 20333217
- Karn, R.C., Young, J.M. and Laukaitis, C.M. (2010) A candidate subspecies discrimination system involving a vomeronasal receptor gene with different alleles fixed in M. m. domesticus and M. m. musculus. PLoS One. 5(9): e12638. PMID: 20844586
- Vošlajerová Bímová, B., Macholán, M., Baird, S.E.B., Munclinger, P., Laukaitis, C.M., Karn, R.C., Luzynski, K., Tucker, P., Piálek, J. (2011) Reinforcement selection acting on the European house mouse hybrid zone. Molecular Ecology. 20(11):2403-24. PMID: 21521395
- Karn, R.C., Mauss, C. and Laukaitis, C.M. (2012) Congenic strain analysis reveals genes that are rapidly evolving components of a prezygotic isolation mediating incipient reinforcement. PLoS One. 7(4):e35898.